Skip to main content
Article thumbnail
Location of Repository

Serum proteins and paraproteins in women with silicone implants and connective tissue disease: a case–control study

By Gyorgy Csako, Rene Costello, Ejaz A Shamim, Terrance P O'Hanlon, Anthony Tran, Daniel J Clauw, H James Williams and Frederick W Miller


Prior studies have suggested abnormalities of serum proteins, including paraproteins, in women with silicone implants but did not control for the presence of connective-tissue disease (CTD). This retrospective case–control study, performed in tertiary-care academic centers, assessed possible alterations of serum proteins, including paraproteins, in such a population. Seventy-four women with silicone implants who subsequently developed CTD, and 74 age-matched and CTD-matched women without silicone implants, were assessed in the primary study; other groups were used for additional comparisons. Routine serum protein determinations and high-sensitivity protein electrophoresis and immunofixation electrophoresis were performed for detection of paraproteins. Women with silicone implants, either with or without CTD, had significantly lower serum total protein and α1-globulin, α2-globulin, β-globulin, γ-globulin, and IgG levels compared with those without silicone implants. There was no significant difference, however, in the frequency of paraproteinemia between women with silicone implants and CTD (9.5%) and age-matched and CTD-matched women without silicone implants (5.4%) (odds ratio, 1.82; 95% confidence interval, 0.51–6.45). Paraprotein isotypes were similar in the two groups, and the clinical characteristics of the 13 women with paraproteinemia were comparable with an independent population of 10 women with silicone breast implants, CTD, and previously diagnosed monoclonal gammopathies. In summary, this first comprehensive study of serum proteins in women with silicone implants and CTD found no substantially increased risk of monoclonal gammopathy. Women with silicone implants, however, had unexpectedly low serum globulin and immunoglobulin levels, with or without the subsequent development of CTD. The causes and clinical implications of these findings require further investigation

Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1996). A critical assessment of the relationship between silicone breast implants and connective tissue diseases. Regul Toxicol Pharmacol
  2. (1999). A formal risk assessment of silicone breast implants. Biomaterials
  3. (1993). AC: Silicone gel breast implants, breast cancer and connective tissue disorders.
  4. (1995). Adami HO: Silicone breast implants and risk of cancer?
  5. (1999). Adjuvancy effect of different types of silicone gel.
  6. (1990). American College of Rheumatology
  7. (1992). Analysis of antibody reactivity in the sera of 42 patients with paraproteinemia. Autoimmunity
  8. (1996). B: Is the risk of multiple myeloma increased in patients with silicone implants? Curr Top Microbiol Immunol
  9. (1996). Basle MF: Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies. Blood
  10. (1994). Calkins DS: Adjuvant breast disease. An evaluation of 100 symptomatic women with breast implants or silicone fluid injections.
  11. (1990). Chelazzi G: Monoclonal gammopathy of uncertain significance in rheumatic disease [in Italian]. Recenti Prog Med
  12. (1988). Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity.
  13. (1982). Deroff P: Monoclonal gammopathies in the adult population of Finistère, France.
  14. (1996). DL: The association of augmentation mammoplasty with connective tissue disease, including systematic sclerosis (scleroderma): a meta-analysis. Curr Top Microbiol Immunol
  15. (1986). Double gammopathies: incidence and clinical course of 20 patients.
  16. (1996). DP: Multiple myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at risk. Curr Top Microbiol Immunol
  17. (1999). Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD.
  18. (2004). Environmental Myositis Study Group: Immunogenetic differences between Caucasian women with and those without silicone implants in whom myositis develops. Arthritis Rheum
  19. (2000). et al.: Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance. Leukemia
  20. (1996). Ezrailson E: Laboratory studies in breast implant patients: ANA positivity, gammaglobulin levels, and other autoantibodies. Curr Top Microbiol Immunol
  21. (1993). Ezrailson EG: Human immune response to polydimethylsiloxane (silicone): screening studies in a breast implant population.
  22. (1997). Facon T: Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition. Blood
  23. (1993). FB: A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med
  24. (1966). Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med Scand
  25. (1994). FW: Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice.
  26. (2000). Hulka BS: Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases.
  27. (1997). III: Complications leading to surgery after breast implantation.
  28. (1999). Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance. Pathol Biol (Paris)
  29. (2006). LJ 3rd: Prevalence of monoclonal gammopathy of undetermined significance.
  30. (2004). Local complications after cosmetic breast implant surgery in Finland. Ann Plast Surg
  31. (1994). Mellemkjaer L: Re: breast implants, cancer, and systemic sclerosis [letter].
  32. (1998). MF: Monocyte-dependent stimulation of human T cells by silicon dioxide. Pathobiology
  33. (1996). MM: Multiple autoimmune manifestations in monoclonal gammopathy of undetermined significance and chronic lymphocytic leukemia. Leukemia
  34. (1991). Monoclonal gammopathies of undetermined significance. Clinical course and biological aspects of 397 cases [in Spanish]. Sangre (Barc)
  35. (1999). Monoclonal gammopathy of undetermined significance (MGUS)-31 year follow up of a community study.
  36. (1996). Monoclonal gammopathy of undetermined significance.
  37. (1971). Osserman EF: Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases.
  38. (1977). Pearson CM: Computerassisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore)
  39. (1999). PH: Association of silicone breast implants with immunologic abnormalities: a prospective study.
  40. (2001). PH: Monoclonal gammopathy of undetermined significance and exposure to breast implants. Arch Intern Med
  41. (1996). Plasmacytoma development in mice injected with silicone gels. Curr Top Microbiol Immunol
  42. (2005). Rajkumar SV: Monoclonal gammopathy of undetermined significance. Clin Lymphoma Myeloma
  43. (2000). Reeves WH: Induction of hypergammaglobulinemia and macrophage activation by silicone gels and oils in female A.SW mice. Clin Diagn Lab Immunol
  44. (1995). RR: A meta-analysis of breast implants and connective tissue disease. Ann Plast Surg
  45. (1996). Silicone gel implants and monoclonal gammopathies: three cases of multiple myeloma and the prevalence of multiple myeloma and monoclonal gammopathy of undetermined significance. Curr Top Microbiol Immunol
  46. (1999). The search for meaning in monoclonal protein. Is it multiple myeloma or monoclonal gammopathy of undetermined significance? Postgrad Med
  47. (1997). Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. [Letter]. Arthritis Rheum
  48. (1999). Y: A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.